Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

ENGlobal Corp. (ENG) Bolsters Management Team, Prepares for Market Growth

Through its engineering and construction group, ENGlobal Corp. (NASDAQ: ENG) delivers innovative, cost-effective automation and specialty construction projects for customers around the world. Consistently included on Engineering News Record magazine’s annual list of the top engineering design firms for more than a decade, the company leverages a wealth of industry experience to serve a variety […]

Green Cures & Botanical Distribution, Inc. (GRCU) Promoting Industry Growth with Aggressive Marketing Campaigns

Green Cures & Botanical Distribution is a leading industrial hemp and botanical products innovator providing a full line of premium hemp-infused nutritional supplements, as well as sports wellness and complete body care products. From concept to distribution, the company is dedicated to the creation and introduction of innovative products that promote a healthy lifestyle. In […]

Neah Power Systems, Inc. (NPWZ) Adds William A. Nitze to Strategic Advisory Board

Today before the opening bell, Neah Power Systems announced the addition of William A. Nitze to the company’s strategic advisory board. “Mr. Nitze’s extensive commercialization, capitalization, international business and focus on off-grid and renewable energy experience will be invaluable to the growth of our Company,” stated Dr. Chris D’Couto, president and CEO of Neah Power […]

Matinas BioPharma Holdings, Inc. (MTNB) Utilizing Proprietary Technology to Improve Safety Profile of Existing Drugs

Matinas Biopharma Holdings is a clinical-stage biopharmaceutical company focused on the development of safe and effective broad spectrum antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections. The company’s proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleate to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally available. Matinas’s lead […]

Giggles N’ Hugs, Inc. (GIGL) Capitalizing on Rising Demand for Organic Dining Options with Family-Friendly Restaurant Chain

In recent years, consumer preference has shifted toward healthier, organic dining options, and the market has experienced rapid growth as a result. According to the Organic Trade Association, total sales of organic products in the United States surpassed $39 billion last year, marking an increase of more than 11 percent over 2013. As the use […]

Aristocrat Group Corp. (ASCC) – Reaching for the Top-Shelf

The Aristocrat Group Corp. (ASCC) has discovered a promised trend extending across the United States: top-shelf spirits are becoming the desired choice for cocktail enthusiasts. Within this sphere of American consumers favoring premium liquor and craft cocktails prepared by mixologists, ASCC is motivated to expand distribution of its ultra-premium distilled spirit, RWB Vodka. With RWB […]

Former Nevada State Senator Joins GrowBLOX Sciences, Inc. (GBLX) as General Manager of GB Sciences Nevada

GrowBLOX Sciences, a biopharmaceutical company with cutting-edge technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today named former Nevada State Senator Sandra Tiffany as general manager of GB Sciences Nevada, LLC. During her 14 years in the legislature, Tiffany held numerous leadership roles and authored key “game changing” legislation. She has […]

 

From Our Blog

HeartBeam Inc. (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year

February 12, 2026

HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration (“FDA”) clearances and approvals across the sector. The recognition underscores HeartBeam’s progress as it advances a novel approach to cardiac diagnostics through its HeartBeam System, a cable-free, high-fidelity […]

Rotate your device 90° to view site.